📰 Given Polypid News
Given Polypid News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Polypid. Real-time updates on events, politics, business and more.
August 27, 2023
PolyPid (NASDAQ:PYPD – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares PolyPid and Merit Medical […]
July 20, 2023
Acutus Medical (NASDAQ:AFIB – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Analyst Recommendations This is a summary of recent […]
June 26, 2023
PolyPid (NASDAQ:PYPD – Get Rating) and Ra Medical Systems (NYSE:RMED – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 2.5% of PolyPid shares are […]
July 3, 2022
Artivion (NYSE:AORT – Get Rating) and PolyPid (NASDAQ:PYPD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Valuation and Earnings This table compares Artivion and PolyPid’s top-line revenue, […]
May 2, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
April 20, 2022
Treace Medical Concepts (NASDAQ:TMCI – Get Rating) and PolyPid (NASDAQ:PYPD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings. Institutional and Insider Ownership 38.8% of Treace Medical Concepts […]